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D
uring a recent review of the England and
Wales domiciliary oxygen service by the
British Thoracic Society Home Oxygen
Working Party, a separate review of paediatric
services was conducted as there are many
differences between the requirements for adults
and children. It soon became clear that there is a
lack of consensus about fundamental paediatric
issues such as the ideal target oxygen saturation.
This is critical as it determines who needs home
oxygen, how much should be given, and when it
is no longer necessary. A lack of agreement and
the enormous variety of practice in babies with
chronic lung disease has been highlighted by
surveys from North America on the initiation of
home oxygen1 and from the UK and Ireland on
weaning off home oxygen.2
This review attempts to offer guidance to
clinicians and service providers. Earlier recom-
mendations for children have been outlined in a
report from the Royal College of Physicians of
London Working Group in 1992 and, although
the main document is no longer available, the
summary can still be obtained.3 The revised 1999
report from the Royal College of Physicians4
included a paediatric section, and much of this
review is based on that, together with relevant
updates. Unfortunately, there is a lack of
randomised controlled trial evidence to inform
much of the debate.
PRINCIPAL DIFFERENCES FROM
TREATMENT OF ADULTS
These can be summarised as follows:
N Most of the clinical conditions in the infant
age group are exclusive and are not seen in
adults, although sometimes there is an over-
lap between older children and young adults.
N The prognosis in infancy is usually good;
many children only need oxygen for a limited
period, although this may be for some years.
N Growth and neurodevelopment are important
considerations.
N Assessment is different, particularly with
regard to the difficulty of arterial blood
sampling.
N Specific equipment is required to allow for low
oxygen flows.
N Almost all children receiving long term oxy-
gen therapy (LTOT) also require ambulatory
oxygen therapy.
N Many children require LTOT overnight only,
especially during the weaning stages; this is
less than the 15 hours that forms part of the
adult LTOT definition.
N All children require supervision from a parent/
carer.
N Provision of oxygen may be necessary at
school for school age children.
LONG TERM OXYGEN THERAPY (LTOT)
LTOT refers to the provision of oxygen therapy
for continuous use at home for patients with
chronic hypoxaemia (due to any cause) in order
to maintain oxygen saturation (SaO2) at or above
92% (depending on the type of oximeter) or
arterial oxygen tension (PaO2) above 8 kPa (see
below). It may be required 24 hours a day or
during periods of sleep only. Any child likely to
require continuous or intermittent oxygen ther-
apy for more than 2–3 weeks should be con-
sidered for discharge home on LTOT. The
principal aims of LTOT are to prevent harm from
chronic hypoxaemia and to improve any relevant
symptoms. It is important to be clear about the
aims for an individual child as this will affect
decisions about target oxygenation (hence titra-
tion and weaning of flow rates).
Principal paediatric conditions requiring
LTOT
The principal associated conditions in children
requiring LTOT are shown in box 1. The list is not
exhaustive and there are a number of other rare
causes of chronic hypoxaemia.
Chronic neonatal lung disease
Chronic neonatal lung disease (CNLD) is the
main indication for LTOT in children. The term
bronchopulmonary dysplasia (BPD) has come to
signify the need for supplemental oxygen at
various postnatal or postmenstrual ages, and the
definition has changed with time. A recent study
of almost 1000 babies born weighing ,1000 g
showed that, although the accuracy was limited,
use of supplemental oxygen at 36 weeks post-
menstrual age was best at predicting long term
pulmonary outcome.5 Infants with CNLD tend to
have been born prematurely and are of very low
birth weight. Data from surviving babies born
weighing ,1500 g showed that 19% developed
CNLD.6 They often require prolonged assisted
ventilation but continue to need supplemental
oxygen once extubated. With increased survival
of extremely low birthweight premature infants,
it is most likely that the incidence of CNLD will
also increase,7 as will the need for LTOT. It has
been suggested that use of supplementary oxy-
gen in CNLD reduces mortality from sudden
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infant death,8 reduces the frequency of intermittent desa-
turations,8 reduces pulmonary hypertension,9 reduces rever-
sible obstructive lung disease,10 improves growth,11 12 and is
likely to be beneficial for neurodevelopment.13 The effect of
oxygen on sleep quality is difficult to interpret but it seems
that desaturations are reduced, but at the cost of sleep
disruption.14–16 Although there have been no randomised
trials of babies on LTOT, it is suggested that caring for babies
on supplementary oxygen at home is preferable to a
prolonged hospital stay.17 It reduces the risk of nosocomial
infection (although friends and relatives who are unwell
should stay away) and it is felt that it is good for parent-child
bonding.13 Finally, it is beneficial in terms of freed resources
for neonatal units and reduces the total cost of care for an
infant.3 17 18
Other neonatal lung conditions
Other neonatal lung conditions include pulmonary hypo-
plasia, congenital pneumonia and meconium aspiration
syndrome but, compared with CNLD, these cases are rare.
Survivors of congenital diaphragmatic hernia repair not
uncommonly develop chronic lung disease, mainly due to
pulmonary hypoplasia or lung damage resulting from
mechanical ventilation. Some require domiciliary oxygen
but this is unusual beyond 2 years of age.19
Congenital heart disease (CHD)
It is likely that only those with pulmonary hypertension
(with or without Eisenmenger syndrome) need to be at home
on long term oxygen. In cyanotic CHD oxygen has little effect
in raising SaO2 and is not indicated, although the degree of
polycythaemia may be reduced.20 However, in some cases
with chronic left to right shunting, irreversible pulmonary
vascular disease can develop and cause right to left shunting
(Eisenmenger syndrome). In the early stages the resulting
pulmonary hypertension may be responsive to oxygen, so this
is indicated while the child is waiting for transplantation or
for palliation. In a small but important controlled study,
100% oxygen given for a minimum of 12 hours per day for up
to 5 years significantly improved survival in children with
pulmonary vascular disease too severe to have corrective
surgery.21 However, this was not the case in a recent 2 year
study of adults with advanced Eisenmenger syndrome where
nocturnal oxygen had no impact on survival, exercise
capacity, or quality of life.22 Some children with CHD who
are awaiting corrective surgery (without Eisenmenger syn-
drome) and who have raised pulmonary artery pressure
which is oxygen responsive may benefit from LTOT. Decisions
for all these cases are made by specialist paediatric
cardiologists.
Pulmonary hypertension
Pulmonary hypertension resulting from pulmonary disease
results from chronic hypoxia and considerably worsens the
overall prognosis.23 Acute hypoxia causes smooth muscle
contraction in pulmonary arteries and sustained hypoxia can
cause adaptation of pulmonary endothelium.23 LTOT reverses
or at least slows the progress of the hypoxic induced changes
to the pulmonary vascular bed and can contribute to
improved survival.23 Primary pulmonary hypertension has a
very poor prognosis in children (median survival ,1 year).
Some of the children desaturate during sleep (especially
during early morning hours) due to mild hypoventilation
which may lead to severe dyspnoea, and the resulting
hypoxaemia can be eliminated by supplemental oxygen.20
Oxygen must also be available for viral upper respiratory tract
infections which may cause some children to desaturate.
Intersti t ial lung disease
Interstitial lung disease represents a spectrum of rare
conditions (such as chronic pneumonitis of infancy, non-
specific interstitial pnuemonitis, desquamative interstitial
pnuemonitis, immunodeficiency) in which oxygen exchange
is impaired. Many of the children require LTOT as well as
drug therapy and the outlook is variable.
Obliterative bronchioli t is
Obliterative bronchiolitis leads to severe obstructive lung
disease and, while it may occur following a viral infection
(e.g. adenovirus), the cause is often unknown. There is no
specific treatment; many of the children require LTOT and
again the outlook is variable.
Cystic fibrosis (CF)
As the treatment for CF improves, there are fewer children
with CF who require LTOT (estimated to be 1–2% paediatric
CF patients). There is surprisingly little evidence for the
benefit of LTOT in CF and, while it led to an improvement in
school or work attendance, there was no effect on mortality
rate, frequency of hospitalisation, or disease progression.24 It
is therefore recommended that LTOT is reserved for those CF
patients who obtain symptomatic relief.25 This is similar to
the indications for palliative care where some children feel
better for having supplemental oxygen. There are other
causes of bronchiectasis in children (although in approxi-
mately 50% cases no underlying cause is found), and
occasionally LTOT is necessary for those with severe disease.
Obstructive sleep apnoea syndrome
Obstructive sleep apnoea syndrome (OSAS) may require non-
invasive ventilation (NIV) if the obstruction cannot be
relieved. Occasionally supplemental oxygen alone is used if
the child does not tolerate the facemask ventilation—for
example, some children with Down’s syndrome. Oxygen does
not suppress the ventilatory drive in the majority of children
with OSAS but PaCO2 should be monitored.
26 It is important
that children with sickle cell disease and upper airway
obstruction do not become hypoxaemic as it can lead to
debilitating episodes of sickling.27 As the incidence of
childhood obesity continues to increase, OSAS is likely to
become a more frequent problem.
Box 1 Principal paediatric conditions requiring
LTOT
N Chronic neonatal lung disease (bronchopulmonary
dysplasia)
N Other neonatal lung conditions (e.g. pulmonary
hypoplasia)
N Congenital heart disease with pulmonary hypertension
N Pulmonary hypertension secondary to pulmonary
disease
N Interstitial lung disease
N Obliterative bronchiolitis
N End stage cystic fibrosis and other causes of severe
bronchiectasis
N Obstructive sleep apnoea syndrome and other sleep
related disorders
N Neuromuscular conditions requiring non-invasive ven-
tilation
N Disorders of the chest wall (e.g. thoracic dystrophy,
severe kyphoscoliosis)
N Palliative care for symptom relief
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Chronic hypoventi lation
There are a number of patients who require long term NIV
because of chronic hypoventilation (to control hypercapnia as
well as hypoxaemia). Oxygen alone is inadequate for most
children with chronic hypoventilation. A UK survey in 1997
estimated the number of children receiving NIV to be 141 of
which 93 (65%) were at home.28 The incidence was shown to
have increased over the previous decade and it is likely that
this will continue to increase in the future. The children had a
variety of conditions, principally neuromuscular disorders
(46%), congenital central hypoventilation syndrome (13%),
spinal injury (12%), craniofacial syndromes (7%), and
bronchopulmonary dysplasia (4%). There were a number of
other less frequent causes (18%). In 35% of cases they had
access to supplemental oxygen at home as well (E Jardine,
personal communication). Core guidelines have suggested
that children on home ventilation should have a stable
oxygen requirement with an FiO2 of usually less than 40%.
29
Assessment in infancy
Suitability for domiciliary oxygen therapy should be assessed
by a specialist with appropriate experience in the care of the
relevant condition; this is usually either a respiratory
paediatrician or a neonatologist (but may be a paediatric
cardiologist, general paediatrician or palliative care specia-
list). The family must also be assessed for their competence to
manage home oxygen therapy and be able to cope with all
aspects of the baby’s care.
In adults the measurement of arterial PaO2 is considered
critical, but this is not always possible or practical in infants.
In paediatric practice, oxygen saturation measured by pulse
oximetry remains the main form of assessment, as results of
an arterial stab from a crying (hypoxic) child is unreliable,
whilst capillary PaO2 does not necessarily correlate with
arterial PaO2.
30 One-off measurements are insufficient and,
before discharge, saturations must be measured continuously
for at least 6–12 hours to include periods of sleep, wakeful-
ness and activity/feeding. It is important to include these
periods as infants have an increased oxygen requirement
during activity and infants with CNLD may develop feeding
related hypoxaemia.31 In addition, some children may only
show evidence of nocturnal hypoxaemia without daytime
hypoxaemia. An instrument should be used that has been
validated in infants and it has been suggested that pulse
oximeter readings should be verified by an arterial gas
measurement at the start of the study; however, this is
usually impractical in children and we do not feel it is
essential. It must still be remembered, however, that
correlation between SaO2 and arterial PaO2 is such that, at
94% saturation, the PaO2 may vary from 9 to 17 kPa.
32
Although correlation is particularly poor in the saturation
range of 85–90%,33 this is not critical as all infants with SaO2
,90% should receive LTOT anyway.
Most of the work in infancy relates to CNLD and there is
only limited evidence to recommend a minimally acceptable
level of oxygenation. The normal SaO2 is around 96% and
supplemental oxygen should be considered for infants who
cannot maintain SaO2 at 93% or above when asleep or quietly
awake.8 Oxygen therapy should be given to achieve an SaO2
above 92% and recommendations have suggested keeping it
at 95% or above.8 However, a recent randomised controlled
study (the ‘‘BOOST’’ trial) in 358 premature infants still
requiring oxygen at 32 weeks postmenstrual age showed that
maintaining SaO2 at 95–98% had no advantage over 91–94%
in terms of growth and neurodevelopment assessed at 1 year
of age (using N-3000 Nellcor oximeters).34 The study also
found that the group with the higher target oxygen level had
an excess of deaths from pulmonary causes, albeit not
statistically significant. This is in keeping with another study
(the ‘‘STOP-ROP’’ trial on retinopathy of prematurity) in
which 649 preterm infants were randomly assigned to
different target oxygen levels (89–94% v 96–99%) for at least
2 weeks.35 They used Ohmeda 3470 oximeters that are
calibrated to display an SaO2 which is lower by 1.6%
saturation points than other commercial oximeters. They
found an increased rate of adverse pulmonary sequelae
(pneumonia and exacerbations of CNLD), although not
deaths, in the high saturation group when assessed at
3 months after the due date of the infant (13.2% v 8.5%). The
high saturation group also had more infants still requiring
supplemental oxygen at 3 months (47% v 37%). Oxygen
toxicity, particularly in premature infants, can inhibit lung
healing and contribute to ongoing lung injury,36 so it would
seem that treatment should aim to keep SaO2 at 92–94% in
infants, particularly during the preterm period, with no more
than 5% of time spent below 90% saturation.
Assessment in older children
In older children adult criteria for oxygen prescription may be
acceptable, although specific studies on upper and lower
limits of PaO2 for LTOT are lacking. It is important to include
an entire night (with at least 4 hours uninterrupted sleep) in
case the child only develops nocturnal hypoxaemia. Data for
normal overnight SaO2 measured by pulse oximetry are
available and a recent study in primary school children
(mean age 9.3 years) showed that the average SaO2 was
approximately 98% and baseline SaO2 ,97% was uncom-
mon.37 Furthermore, while intermittent desaturations by 4%
or more were frequent, the SaO2 rarely fell to 90% or below.
Overnight assessment is important as nocturnal hypoxaemia
usually precedes daytime desaturation in children with CF. In
children with hypoventilation, such as in neuromuscular
disease, it is important to check the carbon dioxide status as,
in the presence of hypercapnia, NIV will be necessary rather
than LTOT alone. Measurement of overnight transcutaneous
or end tidal CO2 is ideal, although a capillary CO2 taken just
as the child wakes up may be useful if the former are not
available. Full polysomnography is not usually required.
Discharge criteria
A multidisciplinary meeting should ensure discharge plan-
ning is achieved properly. Extensive collaboration is required
between the parents and multidisciplinary team, and in some
cases it may be appropriate to include a representative of the
service contractor in discharge planning to ensure carers are
comfortable with the arrangements. The goal is to select the
infants and families most likely to cope at home and to get
the timing of discharge right.38
N Oxygen requirement must be stable with mean SaO2 of
93% or above, without frequent episodes of desaturation.
The SaO2 should not fall below 90% for more than 5% of
the artefact-free recording period.
N Babies should be able to cope with short periods in air
without being at risk of rapid deterioration in case their
nasal cannulae become dislodged. Generally this will apply
to those requiring ,0.5 l/min, but this does not mean that
some babies with a higher oxygen requirement cannot be
on home oxygen.
N No other clinical conditions precluding discharge are
present, and the child is medically stable with satisfactory
growth. No apnoeic episodes for at least 2 weeks.
N Immunisations up to date. Palivizumab (Synagis) may be
considered at the appropriate time of year for infants with
CNLD requiring home oxygen.
N Parents are willing and felt to be capable of taking the
baby home while still on oxygen.
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N Home conditions must be satisfactory and preferably a
telephone should be installed (or use of a mobile phone
available). A visit from a member of the home care team is
required before discharge.
N Parents are trained and have written information on the
use of home oxygen and also cardiopulmonary resuscita-
tion in the case of infants. Vigilance for an empty oxygen
supply, dislodged cannulae, or blocked valve is critical. A
structured education programme can be useful.39
N Advice should be given about no smoking in the home; it
needs to be strongly discouraged but help to do so must be
offered.
N Advice must also be given about open flames (such as
birthday cake candles).40
N Older children also need to have training on how to use
their oxygen equipment.
N Parents must be advised about travel with cylinders and
inform their home and car insurers.
N Appropriate support must be in place—for example,
community nursing, nurse specialists, health visitor, social
workers.
N Communication with general practitioner has taken place
and roles have been clarified for delivering clinical care.
N Parents must have a list of telephone numbers for advice
and emergency help including equipment breakdown.
N Arrangements are in place for open access to the local
paediatric unit.
Equipment
Much of the information on LTOT equipment for adults
applies to children, but there are some specific issues:
N Oxygen concentrators are usually the preferred devices
with back up cylinders for breakdown and portable
cylinders (preferably lightweight) for ambulatory use.
N Oxygen concentrators need two outlets, one in the child’s
bedroom and one in the main living room area.
N Oxygen cylinders may be more appropriate if initial flow
rates are lower than 0.3 l/min and the anticipated duration
of oxygen therapy is less than 3 months. A back up
cylinder must be available for those on continuous oxygen.
Particular attention must be paid to safety and securing of
cylinders in the presence of young children.
N Low flow meter (0.1–1 l/min) must be available for infants
and very young children.
N Humidification system is often required for those on flow
rates above 1 l/min for nasal comfort. Cold bubble
humidifiers may be used for this purpose, but they only
achieve 40% relative humidity and are inadequate for
direct airway humidification (for example, via a tracheos-
tomy). Heated humidification is less convenient for
domestic use and is only effective at flow rates of 4 l/
min or higher delivered by a concentrator as water can
block the tubing at lower flow rates.
N Appropriately sized soft twin prong nasal cannulae (small
children rarely tolerate .2 l/min by nasal cannulae),
facemask, and non-kinking extension tubing must be
provided by the hospital. Stomahesive (or equivalent)
should also be provided to protect the skin in those using
nasal cannulae.
N Ambulatory equipment must be available as part of the
oxygen delivery systems unless oxygen is only required at
night. This must be lightweight so that older children can
handle it themselves, and for infants it must fit on to a
pram/pushchair. Parents need advice on the type of pram
to buy—for example, one with a metal basket underneath
that is safe and strong enough to hold the cylinder.
N Children in wheelchairs need to have a cylinder fitting
provided by their wheelchair service to maintain safety.
Oxygen saturation monitor (pulse oximeter)
The issue of whether parents should be provided with their
own saturation monitor has been an area of debate. If a child
requires continuous monitoring then it is unlikely they are
ready for hospital discharge. There is no evidence that
provision of oximeters improves the outcome of babies on
home oxygen, and in practice may lead to excessive
adjustments of the flow rate by the carers.41 It may give false
reassurance, and oxygen saturation is only one aspect of the
baby’s respiratory status. Some parents, however, request one
for spot measurements as a guide to when oxygen needs
increasing—for example, when the baby has a cold. Our
recommendation would be that the baby should be seen in
these circumstances, usually by the home care nurse who can
then make a full assessment. The use as an overnight
‘‘alarm’’ is unsatisfactory because of the number of false
alarms, mostly from movement artefact. The American
Thoracic Society has supported provision of oximeters to
parents, but their rationale seems to be mostly cost based in
terms of reducing hospital and office visits.42
Patient follow up arrangements
Arrangements for follow up after discharge should be
coordinated by the hospital specialist who has initiated
domiciliary oxygen. Liaison must take place between the
specialist (usually a respiratory paediatrician or neonatolo-
gist), local and/or community paediatrician, general practi-
tioner, nurse specialists (usually based in tertiary respiratory
or neonatal units), community paediatric nursing service,
occupational therapist, and health visitor. A study in Oxford
on 55 babies with CNLD at home with LTOT looked at
healthcare use in 31 of the babies.17 They found that they
received a median of 43 visits per baby (range 8–173) from a
paediatric community nurse, and these lasted a median of
45 minutes; 83% saw a health visitor with a median of 12
visits (range 2–82) and they were for a median of 30 minutes;
83% saw a GP with a median of 6 visits (range 1–140) and
they were for a median of 10 minutes. A lesser proportion
also saw a hospital consultant (they almost all had hospital
clinic visits, however, on a median four occasions), social
worker, physiotherapist and speech therapist.
The oxygen requirement is likely to change with time and,
in the case of infants with CNLD, it should gradually reduce.
Regular home monitoring using pulse oximetry is necessary
and should be set up by community/specialist nurses. A visit
within the first 24 hours is important to allay parental
anxiety. The first formal saturation monitoring should take
place within a week; subsequent recordings should occur
as clinically indicated, but rarely less often than every
3–4 weeks.41 Recorded data can then be discussed with the
supervising consultant although protocols can be in place
for experienced nursing teams to initiate changes. The length
of time infants with CNLD remain on LTOT varies but is
usually 6–12 months, although some require it for several
years.
Infants with CNLD who require home oxygen have more
frequent and longer hospital admissions and more clinic
attendances than those sent home without oxygen.43 This is
particularly the case if they had been hospitalised in the first
2 years of life with RSV infection, which had a significant
impact on cost of care.44 In the Oxford study 41% of the
babies required readmission on a median of 1 occasion (range
0–10), staying for a median 9 days (range 1–64).17 The
children should be seen regularly by the hospital specialist in
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clinic in order to monitor the underlying condition as well as
growth and neurodevelopment. There must be direct access
for the child to be admitted to hospital in the case of any
emergency or acute deterioration in the condition, and the
parents must have the telephone numbers of the team. Even
a simple viral upper respiratory tract infection in a young
infant on LTOT may necessitate admission, and winter
(particularly the first) can be an anxious time for parents.
If the carers believe the child requires an increase in oxygen,
they can turn up the flow rate but must then seek advice
from the home care team.
It is recommended that influenza immunisation should be
given to children with chronic respiratory disease requiring
home oxygen, although the vaccine is not licensed for those
aged under 6 months. In these cases it is worthwhile
immunising household contacts and other caregivers to give
some protection to the child.45
Even when the child comes off oxygen, support must
continue as children may sometimes relapse and require
further periods of oxygen therapy after an apparently
complete recovery. This is usually related to intercurrent
infection.
Weaning off LTOT
The issue of weaning off oxygen principally applies to infants
with CNLD and some other neonatal lung conditions. In
children with congenital heart disease, only those having
successful corrective surgery or transplantation will no longer
require LTOT. Some young children with interstitial lung
disease or obliterative bronchiolitis may improve sufficiently
to lose their oxygen dependency. Older children with
progressive lung disease such as CF or neuromuscular
conditions usually continue to require oxygen for the
remainder of their lives. It is not easy to counsel parents as
to how long LTOT will be needed. Although capillary blood
PaCO2 measured near term correlated with length of oxygen
dependency for a group of babies with CNLD, it was
impossible to predict for an individual.46 However, in general
those with a higher PaCO2 are more likely to require oxygen
for longer. The length of time infants with CNLD remain on
LTOT varies but is usually under 12 months, although some
require it for a number of years.47–49 Persisting symptoms or
failure to progress warrant review to rule out conditions such
as tracheobronchomalacia, large airway stenosis or granu-
loma formation, gastro-oesophageal reflux, recurrent aspira-
tion, or unsuspected congenital cardiac disease.
There is an enormous variety of practice with regard to the
criteria used by paediatricians as to when to discontinue
LTOT in children with CNLD which reflects the lack of
evidence on which to base guidelines.2 Regular reassessment
(usually monthly if the child is stable) in the home using a
pulse oximeter with a data recording facility is necessary.
During periods of weaning or withdrawal of oxygen, more
frequent monitoring will be needed. It is not normally
necessary for the child to have an oxygen saturation monitor
kept in the home as one can be provided for intermittent
monitoring. Recording should include daytime activity,
feeding and sleep. Short term awake SaO2 measurements
do not predict prolonged sleeping SaO2.
50 The same target
saturations used to decide supplementation are used for
weaning purposes (92–94%). Saturation targets in the
physiological range (95–98%) may be felt to be desirable in
infants with pulmonary hypertension. In a study using
2 hour room air challenges, most infants reached their lowest
saturations within 40 minutes of discontinuing oxygen and a
level of 92% or above best predicted readiness for weaning
judged by 6 month follow up.51 Furthermore, infants requir-
ing an oxygen flow rate of 0.02 l/kg/min were most likely to
be successfully weaned.51
Some units wean infants from continuous low flow oxygen
to night time and naps only while others maintain
continuous oxygen until the child has no requirement at
all; there is no evidence to recommend which approach is
best. When the oxygen requirement is minimal, the children
should have supervised weaning into air with continuous
monitoring (that will include active periods and sleep).
Babies tend to be weaned down to an oxygen flow rate of
0.1 l/min using a low flow meter, and from that level they can
usually be weaned straight to air. Although very (or ultra)
low flow meters exist (0.025–0.2 l/min) so that in theory the
flow can be reduced further before weaning to air, it is
usually unnecessary and, in addition, there is a concern that
some carers may become confused by the decimal points.
Weaning is preferably done at home as it minimises the
chances of nosocomial infection, although a brief hospital
admission may sometimes be needed. It is usually prudent to
ensure that the child has coped with at least one viral upper
respiratory tract infection without problems before the
equipment is removed from the home, and it should be left
there for a few months, especially in the winter.
AMBULATORY OXYGEN THERAPY
All children on LTOT require facilities for portable ambulatory
oxygen therapy unless they only use night time oxygen. This
particularly applies to the infant age group (who spend
periods in the day sleeping) as parents will need to be able to
take the baby out of the home in order to lead as normal a life
as possible. It is essential that appropriate equipment is
available—for example, oxygen cylinders that fit on a pram.
The duration of ambulatory oxygen therapy will usually
increase with older children who are rarely ‘‘house bound’’,
but a separate source should be provided at school.
OXYGEN IN SCHOOLS
There is a small but important demand for oxygen therapy to
be available in schools. Liaison is required between the
specialist paediatric respiratory team and the education
health services, and this is usually coordinated by com-
munity paediatric services. The following need particular
consideration:
N Oxygen delivery equipment must be lightweight and easy
for the child to handle and adjust.
N Safety devices must be in place for stabilising oxygen
cylinders or other equipment.
N Insurance cover must be obtained by the school for staff
and premises.
N Adequate technical back up must be available.
N School staff must be trained in the use of oxygen therapy.
N School staff must have easily identified healthcare
contacts.
N Provision must be made for ambulatory oxygen for the
journey to and from school.
SHORT BURST OXYGEN THERAPY
There are no indications specific to children. In any case, they
should be supervised in hospital if they require acute use of
short term oxygen—for example, during severe acute asthma.
CONCLUSIONS
The home oxygen service is undergoing a huge change and,
by integrating the service, there should be improvements for
both prescribers and users. Clearly there are far fewer
children than adults requiring home oxygen but their needs
are quite different. Fortunately this is being taken into
account during the planning stages. The new service should
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also present opportunities for research/audit and redefining
guidelines.
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